Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Malini Madhavan
- Study ID
- NCT04685317
- Status
- Recruiting
Conditions
- Arrhythmia
- Atrial Fibrillation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sentinel® Cerebral Protection System — DEVICEA percutaneously delivered dual-filter protection device, designed to capture and remove debris dislodged during transcatheter aortic valve replacement procedures.
- Magnetic Resonance Imaging — DIAGNOSTIC_TESTCerebral MRI will be performed without gadolinium contrast using a 3 Tesla scanner prior to and 1 to 7 days after catheter ablation
Study Details
The purpose of the study is to see if the Sentinel® Cerebral Protection System may prevent occurrence of stroke during an ablation procedure for atrial fibrillation (AF). The secondary purpose of this study is to study if cognitive function after AF ablation differs between those treated with the Sentinel cerebral protection device and those who do not receive the device.
Key Dates
- Start date
- Mar 7, 2023
- Status verified
- Jun 2025
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Sentinel® Cerebral Protection System GroupSentinel® Cerebral Protection System in patients undergoing AF catheter ablation
- Active Comparator: Standard of Care GroupStandard of care (no cerebral protection device) in patients undergoing AF catheter ablation
Primary Outcome Measure
Incident of overt and covert CNS injury 7 days post AF ablation [ Time Frame: 7 days post AF ablation ]
Central Contacts
- Grace Purkey(507) 255-0774
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Malini Madhavan, MBBS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By condition
By specialty
By research site
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama